Zimmer Biomet Holdings, Inc. (ZBH), headquartered in Warsaw, Indiana, designs, manufactures, and sells medical equipment. Valued at $18.7 billion by market cap, the company offers orthopedic, dental, and spinal reconstructive implants, as well as bone cement and related surgical products.
Shares of medical device giant have underperformed the broader market over the past year. ZBH has declined 3.5% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 20.6%. In 2026, ZBH stock is up 10.7%, compared to the SPX’s 13.9% rise on a YTD basis.